A CASE OF BRONCHIAL ASTHMA DUE TO STRONGER NEO-MINOFAGEN C (SNMC)

Abstract

We generated questionnaire tables for quality of life (QOL) in patients with Parkinson's diA 62-year-old woman visited our hospital because of bronchial asthma and chronic hepatitis. After she received Stronge Neo-minophagen C (SNMC) intravenously, Wheezing and nasal discharge appeared. Therefore, we examined the challenge test of SNMC. 15 cc of SNMC challenge produced nasal discharge, sneezing and dyspnea with a 21% decline in FEV 1.0. SNMC consists of glycyrrhizin, L-cystein, aminoacetic acid and sodium sulfite. In a glycyrrhizin inhalation test, FEV 1.0 values declined 13.6% and she experienced dyspnea and nasal discharge. We suspect that glycyrrhizin induced the asthma attack.